Jim Simons P Lx Pharma Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.3 $2,100 - $5,250	-17,500 Reduced 32.11%	37,000 $5,000
Q4 2022 Feb 13, 2023	BUY	$0.15 - $0.63 $8,175 - $34,335	54,500 New	54,500 $9,000
Q3 2021 Nov 12, 2021	SELL	$12.22 - $21.28 $2.55 Million - $4.45 Million	-208,983 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$9.0 - $15.94 $626,112 - $1.11 Million	-69,568 Reduced 24.97%	208,983 $2.88 Million
Q1 2021 May 13, 2021	BUY	$5.24 - $10.14 $730,812 - $1.41 Million	139,468 Added 100.28%	278,551 $2.52 Million
Q4 2020 Feb 10, 2021	BUY	$3.01 - $6.7 $184,814 - $411,380	61,400 Added 79.04%	139,083 $768,000
Q3 2020 Nov 13, 2020	BUY	$2.83 - $4.21 $10,471 - $15,577	3,700 Added 5.0%	77,683 $251,000
Q2 2020 Aug 13, 2020	SELL	$2.32 - $4.02 $967 - $1,676	-417 Reduced 0.56%	73,983 $240,000
Q1 2020 May 14, 2020	BUY	$1.98 - $5.87 $8,492 - $25,176	4,289 Added 6.12%	74,400 $167,000
Q4 2019 Feb 13, 2020	BUY	$3.36 - $5.04 $4,704 - $7,056	1,400 Added 2.04%	70,111 $306,000
Q3 2019 Nov 13, 2019	BUY	$4.89 - $7.18 $19,560 - $28,720	4,000 Added 6.18%	68,711 $350,000
Q2 2019 Aug 12, 2019	BUY	$4.93 - $7.2 $30,068 - $43,912	6,099 Added 10.41%	64,711 $466,000
Q1 2019 May 14, 2019	BUY	$2.05 - $6.0 $30,544 - $89,400	14,900 Added 34.09%	58,612 $308,000
Q4 2018 Feb 13, 2019	BUY	$1.22 - $4.38 $53,328 - $191,458	43,712 New	43,712 $67,000

61.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.